Journal of Clinical Oncology , 0732-183X

Journal

41 - 50 out of 120Page size: 10

Publications

  1. 2013
  2. Published

    Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis

    Daniel Rea, 20 Jun 2013, In: Journal of Clinical Oncology. 31, 18, p. 2257-2264 8 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone

    Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.

    Research output: Contribution to journal › Abstract › peer-review

  4. Published

    Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial

    Keith Wheatley, 20 May 2013, In: Journal of Clinical Oncology . 31, suppl 15, abstr 10031.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission

    Robert Hills, Keith Wheatley, 1 Apr 2013, In: Journal of Clinical Oncology . 31, 10, p. 1293-301 9 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Muscle invasive bladder cancer in the elderly: Treatment and prognosis in a prospective cohort study

    Tom Wright, Adam Devall, Sarah Pirrie, Lucinda Billingham, KK Cheng, Rik Bryan, 20 Feb 2013, In: Journal of Clinical Oncology . 31, 6_suppl, p. 275

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

    Dickens Pratt & 1 others, , 20 Jan 2013, In: Journal of Clinical Oncology. 31, 3, p. 301-307

    Research output: Contribution to journal › Article › peer-review

  8. 2012
  9. Published

    Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study

    Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia

    Robert Hills, Sylvie Freeman, Charles Craddock, Keith Wheatley, 2012, In: Journal of Clinical Oncology . 30, 32, p. 3924-31 8 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2011
  13. Published

    Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.

    Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...12 Next